RECRUITING

Effect of Osteopathic Manipulative Medicine on Constipation in Parkinson's Disease

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The aim of this pilot study is to investigate the effect of Osteopathic Manipulative Medicine (OMM) in decreasing constipation symptoms in people with Parkinson's disease (PD). A second but optional aim is to determine if OMM changes the bacterial flora of the mouth and gut. OMM is a safe and gentle manual treatment provided by osteopathic physicians. All participants will receive OMM during the second half of the eleven week trial.

Official Title

Effect of Osteopathic Manipulative Medicine on Constipation in Parkinson's Disease

Quick Facts

Study Start:2015-01-01

Study Completion:2024-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT02344485

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Medically diagnosed with Parkinson's disease * Medically diagnosed with constipation (according to Rome III criteria) * Be over 40 years old	* No diagnosis of Parkinson's disease * No diagnosis of constipation that satisfies Rome III criteria * Medically diagnosed with irritable bowel syndrome * Another diagnosed cause for chronic constipation * Currently pregnant * Have another diagnosed neurologic condition (excluding headache or migraine, headache, migraine, dysautonomia, depression or other mood disorders (unless severe or uncontrolled), dementia or cognitive changes (unless severe), diffuse lewy body dementia, REM sleep behavior disorder, normal pressure hydrocephalus, multiple system atrophy P and C types, progressive supranuclear palsy, vascular parkinsonism, corticobasal ganglionic degeneration, and drug induced parkinsonism) * Spinal cord abnormality or lesion * Cancer of the gastrointestinal tract, abdomen, or pelvis * Anemia that has not been evaluated * Unexplained weight loss, fever, night sweats, rectal bleeding, or black stools in past 2 months * Active hepatitis, infectious mononucleosis, or enlarged spleen * Abdominal aortic aneurysm * Congenital malformation of the gastrointestinal tract * Abdominal or pelvic surgery within the past 6 weeks * Unable or unwilling to receive OMT. * Unable or unwilling to rate one's own stools using a visual chart or to bring a picture of one's stool to each visit

Inclusion Criteria

Exclusion Criteria

* Medically diagnosed with Parkinson's disease
* Medically diagnosed with constipation (according to Rome III criteria)
* Be over 40 years old

* No diagnosis of Parkinson's disease
* No diagnosis of constipation that satisfies Rome III criteria
* Medically diagnosed with irritable bowel syndrome
* Another diagnosed cause for chronic constipation
* Currently pregnant
* Have another diagnosed neurologic condition (excluding headache or migraine, headache, migraine, dysautonomia, depression or other mood disorders (unless severe or uncontrolled), dementia or cognitive changes (unless severe), diffuse lewy body dementia, REM sleep behavior disorder, normal pressure hydrocephalus, multiple system atrophy P and C types, progressive supranuclear palsy, vascular parkinsonism, corticobasal ganglionic degeneration, and drug induced parkinsonism)
* Spinal cord abnormality or lesion
* Cancer of the gastrointestinal tract, abdomen, or pelvis
* Anemia that has not been evaluated
* Unexplained weight loss, fever, night sweats, rectal bleeding, or black stools in past 2 months
* Active hepatitis, infectious mononucleosis, or enlarged spleen
* Abdominal aortic aneurysm
* Congenital malformation of the gastrointestinal tract
* Abdominal or pelvic surgery within the past 6 weeks
* Unable or unwilling to receive OMT.
* Unable or unwilling to rate one's own stools using a visual chart or to bring a picture of one's stool to each visit

Contacts and Locations

Study Contact

Jayme Mancini, D.O.

CONTACT

516-686-1237

jmancini@nyit.edu

Principal Investigator

Jayme Mancini, D.O.

PRINCIPAL_INVESTIGATOR

New York Institute of Technology- Academic Health Care Center

Study Locations (Sites)

New York Institute of Technology- Academic Health Care Center

Old Westbury, New York, 11568

United States

Collaborators and Investigators

Sponsor: New York Institute of Technology

Jayme Mancini, D.O., PRINCIPAL_INVESTIGATOR, New York Institute of Technology- Academic Health Care Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2015-01-01

Study Completion Date2024-12-31

Study Record Updates

Study Start Date2015-01-01

Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

Parkinson's Disease
Constipation